806 results on '"Suzuki, Yuzo"'
Search Results
2. CXCL10 predicts autoimmune features and a favorable clinical course in patients with IIP: post hoc analysis of a prospective and multicenter cohort study
3. Antifibrotics and mortality in idiopathic pulmonary fibrosis: external validity and avoidance of immortal time bias
4. Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study
5. Pan-cancer assessment of antineoplastic therapy-induced interstitial lung disease in patients receiving subsequent therapy immediately following immune checkpoint blockade therapy
6. Association of constipation with the survival of patients with idiopathic interstitial pneumonias
7. Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy
8. Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer
9. Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: A prospective, multicentre cohort study
10. Neutrophil–lymphocyte ratio being associated with mortality risk in patients receiving antifibrotic therapy
11. Characterization of BRAFThr599dup Mutation as a Targetable Driver Mutation Identified in Lung Adenocarcinoma by Comprehensive Genomic Profiling
12. Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 study
13. High-level production of 2-pyrone-4,6-dicarboxylic acid from vanillic acid as a lignin-related aromatic compound by metabolically engineered fermentation to realize industrial valorization processes of lignin
14. A GWAS approach identifies Dapp1 as a determinant of air pollution-induced airway hyperreactivity.
15. Treatments of refractory eosinophilic lung diseases with biologics
16. Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial
17. Integrated process development for grass biomass utilization through enzymatic saccharification and upgrading hydroxycinnamic acids via microbial funneling
18. Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physicians
19. Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study
20. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
21. Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis
22. Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases
23. Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium
24. Associations of serum long-chain fatty acids with multiple organ involvement in patients with sarcoidosis
25. Obesity impairs ciliary function and mucociliary clearance in the murine airway epithelium.
26. Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer
27. Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis
28. Lignin valorization through efficient microbial production of β-ketoadipate from industrial black liquor
29. Conventional type 2 lung dendritic cells are potent inducers of follicular helper T cells in the asthmatic lung
30. Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung disease
31. Prophylactic granulocyte-colony stimulating factor in patients with lung neuroendocrine carcinoma receiving platinum agents plus etoposide
32. Palliative Care for Idiopathic Pulmonary Fibrosis Patients: Pulmonary Physicians' View
33. Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis
34. Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study
35. Development of the production of 2-pyrone-4,6-dicarboxylic acid from lignin extracts, which are industrially formed as by-products, as raw materials
36. Quantitative computed tomography measures of skeletal muscle mass in patients with idiopathic pulmonary fibrosis according to a multidisciplinary discussion diagnosis: A retrospective nationwide study in Japan
37. CT assessment of the normal upper-lobe lung volume in idiopathic pleuroparenchymal fibroelastosis
38. Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations
39. Prognostic role of interferon‐lambda 3 in anti‐MDA5–positive dermatomyositis‐associated ILD
40. Neutrophil–lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis
41. Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival
42. Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study
43. Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy
44. Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study
45. Simple method for detecting idiopathic interstitial pneumonias by measuring vertical lung length on chest X-ray
46. Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias
47. Diagnostic and prognostic significance of serum angiopoietin-1 and -2 concentrations in patients with pulmonary hypertension
48. Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis
49. Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis
50. Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.